Concomitant plasmacytoma and B cell lymphoma with discordant light chain expression but clonal identity

por Au, Wing Y., Wai-Hung, Lau, Wong, Kai Y., Choi, William W. L.
Publicado 2012

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

por Ye, Qing, Xu-Monette, Zijun Y., Tzankov, Alexandar, Deng, Lijuan, Wang, Xiaoxiao, Manyam, Ganiraju C., Visco, Carlo, Montes-Moreno, Santiago, Zhang, Li, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Parsons, Ben M., Møller, Michael B., Piris, Miguel A., Winter, Jane N., Medeiros, L. Jeffrey, Hu, Shimin, Young, Ken H.
Publicado 2015

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma

por Zhang, Mingzhi, Xu-Monette, Zijun Y., Li, Ling, Manyam, Ganiraju C., Visco, Carlo, Tzankov, Alexandar, Wang, Jing, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., Han van Krieken, J., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Jeffrey Medeiros, L., Pham, Lan V., Young, Ken H.
Publicado 2016

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

por Deng, Manman, Zhang, Mingzhi, Xu-Monette, Zijun Y., Pham, Lan V., Tzankov, Alexandar, Visco, Carlo, Fang, Xiaosheng, Bhagat, Govind, Zhu, Feng, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Choi, William W. L., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Parsons, Benjamin M., van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Hagemeister, Fredrick, Alinari, Lapo, Li, Yong, Andreeff, Michael, Xu, Bing, Young, Ken H.
Publicado 2020

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

por Chen, Jiayu, Xu-Monette, Zijun Y., Deng, Lijuan, Shen, Qi, Manyam, Ganiraju C., Martinez-Lopez, Azahara, Zhang, Li, Montes-Moreno, Santiago, Visco, Carlo, Tzankov, Alexandar, Yin, Lihui, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Farnen, John P., Winter, Jane N., Piris, Miguel A., Pham, Lan, Young, Ken H.
Publicado 2015

Clinical and biological significance of de novo CD5(+) diffuse large B-cell lymphoma in Western countries

por Xu-Monette, Zijun Y., Tu, Meifeng, Jabbar, Kausar J., Cao, Xin, Tzankov, Alexandar, Visco, Carlo, Cai, Qingqing, Montes-Moreno, Santiago, An, Yuji, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Farnen, John P., Winter, Jane N., Piris, Miguel A., Miranda, Roberto N., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

por Li, Ling, Xu-Monette, Zijun Y., Ok, Chi Young, Tzankov, Alexandar, Manyam, Ganiraju C., Sun, Ruifan, Visco, Carlo, Zhang, Mingzhi, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Wang, Jinfeng, Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Pham, Lan V., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2015

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

por Xu-Monette, Zijun Y., Zhang, Shanxiang, Li, Xin, Manyam, Ganiraju C., Wang, Xiao-xiao, Xia, Yi, Visco, Carlo, Tzankov, Alexandar, Zhang, Li, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2016

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary?

por Ok, Chi Young, Ye, Qing, Li, Ling, Manyam, Ganiraju C., Deng, Lijuan, Goswami, Rashmi R., Wang, Xiaoxiao, Montes-Moreno, Santiago, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Zhang, Li, Abramson, Jeremy, Sohani, Aliyah R., Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhang, Shanxiang, Parsons, Ben M., Xu, Mina, Møller, Michael B., Winter, Jane N., Piris, Miguel A., Xu-Monette, Zijun Y., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2015

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

por Wang, Xiaoxiao, Cao, Xin, Sun, Ruifang, Tang, Charlene, Tzankov, Alexandar, Zhang, Jun, Manyam, Ganiraju C., Xiao, Min, Miao, Yi, Jabbar, Kausar, Tan, Xiaohong, Pang, Yuyang, Visco, Carlo, Xie, Yan, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Li, Shaoying, Miranda, Roberto N., Medeiros, L. Jeffrey, Li, Yong, Xu-Monette, Zijun Y., Young, Ken H.
Publicado 2018